Literature DB >> 16189639

Post-infectious acute glomerulonephritis with predominant mesangial deposition of IgA.

Keith K Lau, Noel M Delos Santos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16189639     DOI: 10.1007/s10157-005-0370-y

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


× No keyword cloud information.
  5 in total

1.  Acute poststreptococcal glomerulonephritis mimicking Henoch-Schönlein purpura.

Authors:  H Matsukura; A Ohtsuki; T Fuchizawa; T Miyawaki
Journal:  Clin Nephrol       Date:  2003-01       Impact factor: 0.975

2.  Histologically confirmed superimposition of post-streptococcal acute glomerulonephritis during IgA nephropathy.

Authors:  Yoshio Horita; Masato Tadokoro; Koichi Taura; Naofumi Suyama; Takashi Taguchi; Masanobu Miyazaki; Shigeru Kohno
Journal:  Clin Exp Nephrol       Date:  2004-12       Impact factor: 2.801

3.  Acute poststreptococcal glomerulonephritis mimicking Henoch-Schönlein purpura.

Authors:  P R Goodyer; J P de Chadarevian; B S Kaplan
Journal:  J Pediatr       Date:  1978-09       Impact factor: 4.406

4.  Localization of glomerular "deposits" in Henoch--Schönlein nephritis.

Authors:  J M Heaton; D R Turner; J S Cameron
Journal:  Histopathology       Date:  1977-03       Impact factor: 5.087

5.  IgA-dominant acute poststaphylococcal glomerulonephritis complicating diabetic nephropathy.

Authors:  Samih H Nasr; Glen S Markowitz; Joseph D Whelan; Joseph J Albanese; Raquel M Rosen; Deborah A Fein; Stanley S Kim; Vivette D D'Agati
Journal:  Hum Pathol       Date:  2003-12       Impact factor: 3.466

  5 in total
  2 in total

Review 1.  Post-streptococcal acute glomerulonephritis in children: clinical features and pathogenesis.

Authors:  T Matthew Eison; Bettina H Ault; Deborah P Jones; Russell W Chesney; Robert J Wyatt
Journal:  Pediatr Nephrol       Date:  2010-07-23       Impact factor: 3.714

2.  Tubulointerstitial nephritis and IgA nephropathy in a patient with advanced lung cancer treated with long-term gefitinib.

Authors:  Kohsuke Masutani; Kiichiro Fujisaki; Hiroto Maeda; Jiro Toyonaga; Ichiro Inoshima; Koichi Takayama; Ritsuko Katafuchi; Hideki Hirakata; Kazuhiko Tsuruya; Mitsuo Iida
Journal:  Clin Exp Nephrol       Date:  2008-06-25       Impact factor: 2.617

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.